Corte, M Daniela <br/><br/>
Tissue-type plasminogen activator (tPA) in breast cancer: relationship with clinicopathological parameters and prognostic significance.  [electronic resource] 

 -  Breast cancer research and treatment  Mar 2005 
 - 33-40 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-6806 
<br/><br/><label>Standard No.: </label>10.1007/s10549-004-2624-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--mortality<br/>Chemotherapy, Adjuvant<br/>Cytosol--metabolism<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Middle Aged<br/>Predictive Value of Tests<br/>Proportional Hazards Models<br/>Spain--epidemiology<br/>Statistics, Nonparametric<br/>Survival Rate<br/>Tissue Plasminogen Activator--metabolism